Being able to attract former executives of Fortune 1000 companies to the boards and management of three investee firms not only brings big-hitting expertise but provides a form of third-party validation of TekCapital PLC’s (LON:TEK) opportunities.
Belluscura
Bob Rauker, chief executive, was previously at Synthes (sold to J&J for US$19.7bn) and Boston Scientific (NYSE:BSX)
Dr Raymond Bray, VP and previously at St. Jude Medical (acquired by Abbott (NYSE:ABT).
Lucyd
Gina Avila, global marketing manager, previously ran the online optics business for Four Eyes, a major chain of 116 optics stores in the U.S. which was acquired by Grandvision (EPA:GVNY).
Salarius
Eduardo Souchon, director, was previously at Pringles (owned by Kellogg’s (NYSE:K)).
Steve McCready, director, previously at Albertsons, a leading chain of 2,339 supermarkets in the US (NYSE:ABS).
Victor Manzanilla, chief executive, previously served as marketing director of Office Depot (NASDAQ:ODP), an office products chain with approximately 1,400 stores, and brand manager at Procter & Gamble (NYSE:PG).
“I’m unaware of any other AIM company that has assembled such a cadre of seasoned talent to commercialise early stage university innovations,” said Tekcapital chief executive Clifford Gross.